innoVactiv Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Quebec City QE Canada (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2008
NCT00797394
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

innoVactiv Inc.

Active Ingredients

Drugs in Phase 2 Trials (3)

2007rd01 (1 trial)

saw palmetto (1 trial)

saw palmetto lipidic extract (1 trial)

Drugs in Phase 1 Trials (2)

2006-rd-05 (1 trial)

brown seaweed (3 trials)

Drugs in Other Trials (1)

brown seaweed extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 2)

Prostatic Hyperplasia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 6